TradingKey – UnitedHealth Group (UNH) has shown good progress on its operational turnaround, but fresh Medicare Advantage (MA) Star Ratings and increased regulatory scrutiny present new risks. UNH closed at $370.95 on October 8, down 1.34%, for a market cap of  approximately $333B.

What is most interesting is the rapid change in the investment case for UNH. Earlier in the year, the focus was on the 2025 Medical Utilization Shock and whether UNH could control costs post-2025. Q2 results show the company is on track to recover post-2025 costs, but the market must take into account how UNH will be impacted by recent Star Rating downgrades and ongoing regulatory investigations.